nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—SCN5A—dilated cardiomyopathy	0.745	1	CbGaD
Quinidine barbiturate—SCN5A—purkinje fiber—dilated cardiomyopathy	0.035	0.293	CbGeAlD
Quinidine barbiturate—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0215	0.18	CbGeAlD
Quinidine barbiturate—SCN5A—endocardium—dilated cardiomyopathy	0.018	0.151	CbGeAlD
Quinidine barbiturate—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0171	0.143	CbGeAlD
Quinidine barbiturate—KCNH2—endocardium—dilated cardiomyopathy	0.0111	0.0929	CbGeAlD
Quinidine barbiturate—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.00296	0.0301	CcSEcCtD
Quinidine barbiturate—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00283	0.0288	CcSEcCtD
Quinidine barbiturate—Uremia—Lisinopril—dilated cardiomyopathy	0.00282	0.0286	CcSEcCtD
Quinidine barbiturate—Quinidine—SCN5A—dilated cardiomyopathy	0.00257	0.448	CrCbGaD
Quinidine barbiturate—KCNK1—cardiac ventricle—dilated cardiomyopathy	0.00254	0.0213	CbGeAlD
Quinidine barbiturate—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00244	0.0249	CcSEcCtD
Quinidine barbiturate—KCNK1—myocardium—dilated cardiomyopathy	0.00239	0.02	CbGeAlD
Quinidine barbiturate—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—ACTN2—dilated cardiomyopathy	0.00237	0.076	CbGpPWpGaD
Quinidine barbiturate—Anuria—Lisinopril—dilated cardiomyopathy	0.00204	0.0207	CcSEcCtD
Quinidine barbiturate—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.0018	0.0183	CcSEcCtD
Quinidine barbiturate—KCNK1—Potassium Channels—ABCC9—dilated cardiomyopathy	0.00176	0.0567	CbGpPWpGaD
Quinidine barbiturate—Quinine—SLC22A5—dilated cardiomyopathy	0.00168	0.294	CrCbGaD
Quinidine barbiturate—KCNK1—heart—dilated cardiomyopathy	0.00167	0.014	CbGeAlD
Quinidine barbiturate—Drug eruption—Furosemide—dilated cardiomyopathy	0.00154	0.0157	CcSEcCtD
Quinidine barbiturate—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.00152	0.0127	CbGeAlD
Quinidine barbiturate—Quinidine—SLC22A5—dilated cardiomyopathy	0.00148	0.258	CrCbGaD
Quinidine barbiturate—SCN5A—myocardium—dilated cardiomyopathy	0.00143	0.012	CbGeAlD
Quinidine barbiturate—KCNK1—cardiac atrium—dilated cardiomyopathy	0.00143	0.012	CbGeAlD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—MYH6—dilated cardiomyopathy	0.00141	0.0451	CbGpPWpGaD
Quinidine barbiturate—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00137	0.0139	CcSEcCtD
Quinidine barbiturate—Azotaemia—Lisinopril—dilated cardiomyopathy	0.00133	0.0136	CcSEcCtD
Quinidine barbiturate—Blister—Furosemide—dilated cardiomyopathy	0.00132	0.0134	CcSEcCtD
Quinidine barbiturate—Lethargy—Spironolactone—dilated cardiomyopathy	0.00129	0.0131	CcSEcCtD
Quinidine barbiturate—Blindness—Lisinopril—dilated cardiomyopathy	0.00128	0.0131	CcSEcCtD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—TNNI3—dilated cardiomyopathy	0.00125	0.0402	CbGpPWpGaD
Quinidine barbiturate—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00124	0.0126	CcSEcCtD
Quinidine barbiturate—Ataxia—Spironolactone—dilated cardiomyopathy	0.00119	0.0121	CcSEcCtD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—ACTN2—dilated cardiomyopathy	0.00117	0.0376	CbGpPWpGaD
Quinidine barbiturate—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00114	0.0116	CcSEcCtD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—TNNT2—dilated cardiomyopathy	0.00106	0.0342	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Cardiac Progenitor Differentiation—ACTC1—dilated cardiomyopathy	0.00106	0.0342	CbGpPWpGaD
Quinidine barbiturate—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.00104	0.0105	CcSEcCtD
Quinidine barbiturate—SCN5A—heart—dilated cardiomyopathy	0.000997	0.00835	CbGeAlD
Quinidine barbiturate—Hearing impaired—Furosemide—dilated cardiomyopathy	0.000996	0.0101	CcSEcCtD
Quinidine barbiturate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000975	0.00992	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000966	0.00983	CcSEcCtD
Quinidine barbiturate—Renal failure—Spironolactone—dilated cardiomyopathy	0.000958	0.00975	CcSEcCtD
Quinidine barbiturate—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.000949	0.0305	CbGpPWpGaD
Quinidine barbiturate—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.000934	0.00782	CbGeAlD
Quinidine barbiturate—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.000929	0.00945	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000909	0.00925	CcSEcCtD
Quinidine barbiturate—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00089	0.00905	CcSEcCtD
Quinidine barbiturate—KCNH2—myocardium—dilated cardiomyopathy	0.000878	0.00736	CbGeAlD
Quinidine barbiturate—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000853	0.00714	CbGeAlD
Quinidine barbiturate—CHRM2—heart—dilated cardiomyopathy	0.000849	0.00711	CbGeAlD
Quinidine barbiturate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000827	0.00842	CcSEcCtD
Quinidine barbiturate—Mental disability—Furosemide—dilated cardiomyopathy	0.000823	0.00837	CcSEcCtD
Quinidine barbiturate—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000787	0.00801	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Furosemide—dilated cardiomyopathy	0.000784	0.00797	CcSEcCtD
Quinidine barbiturate—Oliguria—Lisinopril—dilated cardiomyopathy	0.000772	0.00785	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00077	0.0247	CbGpPWpGaD
Quinidine barbiturate—Deafness—Furosemide—dilated cardiomyopathy	0.000769	0.00783	CcSEcCtD
Quinidine barbiturate—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000762	0.00775	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000739	0.0237	CbGpPWpGaD
Quinidine barbiturate—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000729	0.00742	CcSEcCtD
Quinidine barbiturate—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00072	0.00732	CcSEcCtD
Quinidine barbiturate—Purpura—Furosemide—dilated cardiomyopathy	0.000714	0.00726	CcSEcCtD
Quinidine barbiturate—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.000711	0.00724	CcSEcCtD
Quinidine barbiturate—Lethargy—Furosemide—dilated cardiomyopathy	0.000702	0.00714	CcSEcCtD
Quinidine barbiturate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000682	0.00694	CcSEcCtD
Quinidine barbiturate—Photophobia—Lisinopril—dilated cardiomyopathy	0.000668	0.00679	CcSEcCtD
Quinidine barbiturate—Irritability—Furosemide—dilated cardiomyopathy	0.000657	0.00668	CcSEcCtD
Quinidine barbiturate—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000633	0.00644	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000628	0.00639	CcSEcCtD
Quinidine barbiturate—Confusional state—Spironolactone—dilated cardiomyopathy	0.000627	0.00638	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00062	0.0063	CcSEcCtD
Quinidine barbiturate—KCNH2—heart—dilated cardiomyopathy	0.000613	0.00513	CbGeAlD
Quinidine barbiturate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000609	0.00619	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000607	0.00617	CcSEcCtD
Quinidine barbiturate—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000588	0.00598	CcSEcCtD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—GJA1—dilated cardiomyopathy	0.000584	0.0188	CbGpPWpGaD
Quinidine barbiturate—Eczema—Lisinopril—dilated cardiomyopathy	0.000574	0.00584	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000574	0.0184	CbGpPWpGaD
Quinidine barbiturate—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000572	0.00582	CcSEcCtD
Quinidine barbiturate—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000559	0.00569	CcSEcCtD
Quinidine barbiturate—Somnolence—Spironolactone—dilated cardiomyopathy	0.000553	0.00562	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000543	0.00552	CcSEcCtD
Quinidine barbiturate—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000542	0.00552	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000537	0.00546	CcSEcCtD
Quinidine barbiturate—KCNH2—Potassium Channels—ABCC9—dilated cardiomyopathy	0.000532	0.0171	CbGpPWpGaD
Quinidine barbiturate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00053	0.00539	CcSEcCtD
Quinidine barbiturate—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000529	0.00538	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000526	0.00535	CcSEcCtD
Quinidine barbiturate—KCNH2—cardiac atrium—dilated cardiomyopathy	0.000524	0.00439	CbGeAlD
Quinidine barbiturate—Renal failure—Furosemide—dilated cardiomyopathy	0.000521	0.0053	CcSEcCtD
Quinidine barbiturate—Diplopia—Lisinopril—dilated cardiomyopathy	0.000516	0.00525	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000512	0.00521	CcSEcCtD
Quinidine barbiturate—Sweating—Furosemide—dilated cardiomyopathy	0.000508	0.00517	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000495	0.00503	CcSEcCtD
Quinidine barbiturate—Urticaria—Spironolactone—dilated cardiomyopathy	0.000494	0.00502	CcSEcCtD
Quinidine barbiturate—Irritability—Lisinopril—dilated cardiomyopathy	0.000493	0.00501	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000491	0.005	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000491	0.00499	CcSEcCtD
Quinidine barbiturate—Ataxia—Lisinopril—dilated cardiomyopathy	0.000485	0.00494	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000472	0.0048	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00047	0.00478	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000467	0.00475	CcSEcCtD
Quinidine barbiturate—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000467	0.00475	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000465	0.00473	CcSEcCtD
Quinidine barbiturate—Visual impairment—Furosemide—dilated cardiomyopathy	0.000459	0.00467	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000458	0.00466	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00045	0.00458	CcSEcCtD
Quinidine barbiturate—Asthma—Lisinopril—dilated cardiomyopathy	0.000446	0.00454	CcSEcCtD
Quinidine barbiturate—GRIA2—N-cadherin signaling events—RAC1—dilated cardiomyopathy	0.000445	0.0143	CbGpPWpGaD
Quinidine barbiturate—Eye disorder—Furosemide—dilated cardiomyopathy	0.000445	0.00453	CcSEcCtD
Quinidine barbiturate—Tinnitus—Furosemide—dilated cardiomyopathy	0.000444	0.00452	CcSEcCtD
Quinidine barbiturate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00044	0.00447	CcSEcCtD
Quinidine barbiturate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000439	0.00447	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000438	0.0141	CbGpPWpGaD
Quinidine barbiturate—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000435	0.00442	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00043	0.00437	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000425	0.00433	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000424	0.00431	CcSEcCtD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000422	0.0136	CbGpPWpGaD
Quinidine barbiturate—Neutropenia—Lisinopril—dilated cardiomyopathy	0.000417	0.00424	CcSEcCtD
Quinidine barbiturate—Erythema—Furosemide—dilated cardiomyopathy	0.000414	0.00422	CcSEcCtD
Quinidine barbiturate—Malnutrition—Furosemide—dilated cardiomyopathy	0.000414	0.00422	CcSEcCtD
Quinidine barbiturate—Dizziness—Spironolactone—dilated cardiomyopathy	0.000411	0.00418	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000409	0.0131	CbGpPWpGaD
Quinidine barbiturate—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000407	0.00414	CcSEcCtD
Quinidine barbiturate—Vomiting—Spironolactone—dilated cardiomyopathy	0.000395	0.00402	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000394	0.00401	CcSEcCtD
Quinidine barbiturate—Rash—Spironolactone—dilated cardiomyopathy	0.000392	0.00399	CcSEcCtD
Quinidine barbiturate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000392	0.00398	CcSEcCtD
Quinidine barbiturate—Renal failure—Lisinopril—dilated cardiomyopathy	0.000391	0.00398	CcSEcCtD
Quinidine barbiturate—Vision blurred—Furosemide—dilated cardiomyopathy	0.000391	0.00397	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00039	0.0125	CbGpPWpGaD
Quinidine barbiturate—Headache—Spironolactone—dilated cardiomyopathy	0.000389	0.00396	CcSEcCtD
Quinidine barbiturate—Jaundice—Lisinopril—dilated cardiomyopathy	0.000388	0.00395	CcSEcCtD
Quinidine barbiturate—Sweating—Lisinopril—dilated cardiomyopathy	0.000381	0.00388	CcSEcCtD
Quinidine barbiturate—Agitation—Furosemide—dilated cardiomyopathy	0.000381	0.00387	CcSEcCtD
Quinidine barbiturate—Vertigo—Furosemide—dilated cardiomyopathy	0.000372	0.00379	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000371	0.00378	CcSEcCtD
Quinidine barbiturate—Leukopenia—Furosemide—dilated cardiomyopathy	0.000371	0.00377	CcSEcCtD
Quinidine barbiturate—Nausea—Spironolactone—dilated cardiomyopathy	0.000369	0.00376	CcSEcCtD
Quinidine barbiturate—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000364	0.0037	CcSEcCtD
Quinidine barbiturate—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000357	0.00363	CcSEcCtD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.000357	0.0115	CbGpPWpGaD
Quinidine barbiturate—Hallucination—Lisinopril—dilated cardiomyopathy	0.000355	0.00362	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000353	0.00359	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00035	0.00356	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00035	0.00356	CcSEcCtD
Quinidine barbiturate—Confusional state—Furosemide—dilated cardiomyopathy	0.000341	0.00347	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000338	0.00344	CcSEcCtD
Quinidine barbiturate—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000333	0.00339	CcSEcCtD
Quinidine barbiturate—Shock—Furosemide—dilated cardiomyopathy	0.000333	0.00339	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000332	0.00337	CcSEcCtD
Quinidine barbiturate—Flushing—Lisinopril—dilated cardiomyopathy	0.000331	0.00337	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000331	0.00337	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000329	0.0106	CbGpPWpGaD
Quinidine barbiturate—Skin disorder—Furosemide—dilated cardiomyopathy	0.000328	0.00334	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000327	0.00333	CcSEcCtD
Quinidine barbiturate—Anorexia—Furosemide—dilated cardiomyopathy	0.000322	0.00328	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000322	0.00327	CcSEcCtD
Quinidine barbiturate—Chills—Lisinopril—dilated cardiomyopathy	0.00032	0.00326	CcSEcCtD
Quinidine barbiturate—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.000316	0.0102	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Furosemide—dilated cardiomyopathy	0.000316	0.00321	CcSEcCtD
Quinidine barbiturate—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000313	0.00318	CcSEcCtD
Quinidine barbiturate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000311	0.00316	CcSEcCtD
Quinidine barbiturate—Erythema—Lisinopril—dilated cardiomyopathy	0.000311	0.00316	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.000311	0.00998	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000308	0.0099	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.000308	0.00989	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.000306	0.00981	CbGpPWpGaD
Quinidine barbiturate—Tension—Lisinopril—dilated cardiomyopathy	0.000305	0.0031	CcSEcCtD
Quinidine barbiturate—Nervousness—Lisinopril—dilated cardiomyopathy	0.000302	0.00307	CcSEcCtD
Quinidine barbiturate—Somnolence—Furosemide—dilated cardiomyopathy	0.000301	0.00306	CcSEcCtD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0003	0.00963	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000294	0.00299	CcSEcCtD
Quinidine barbiturate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000293	0.00298	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000292	0.00297	CcSEcCtD
Quinidine barbiturate—Tremor—Lisinopril—dilated cardiomyopathy	0.000291	0.00296	CcSEcCtD
Quinidine barbiturate—Constipation—Furosemide—dilated cardiomyopathy	0.000289	0.00294	CcSEcCtD
Quinidine barbiturate—Pain—Furosemide—dilated cardiomyopathy	0.000289	0.00294	CcSEcCtD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.000289	0.00928	CbGpPWpGaD
Quinidine barbiturate—Angioedema—Lisinopril—dilated cardiomyopathy	0.000284	0.00289	CcSEcCtD
Quinidine barbiturate—Vertigo—Lisinopril—dilated cardiomyopathy	0.000279	0.00284	CcSEcCtD
Quinidine barbiturate—Syncope—Lisinopril—dilated cardiomyopathy	0.000279	0.00284	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000279	0.00284	CcSEcCtD
Quinidine barbiturate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000278	0.00283	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000278	0.00893	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000277	0.00281	CcSEcCtD
Quinidine barbiturate—Palpitations—Lisinopril—dilated cardiomyopathy	0.000275	0.0028	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000273	0.00278	CcSEcCtD
Quinidine barbiturate—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00027	0.00867	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Furosemide—dilated cardiomyopathy	0.000269	0.00273	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000267	0.00272	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000267	0.00272	CcSEcCtD
Quinidine barbiturate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—RAF1—dilated cardiomyopathy	0.000266	0.00855	CbGpPWpGaD
Quinidine barbiturate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000265	0.00269	CcSEcCtD
Quinidine barbiturate—Myalgia—Lisinopril—dilated cardiomyopathy	0.000265	0.00269	CcSEcCtD
Quinidine barbiturate—Chest pain—Lisinopril—dilated cardiomyopathy	0.000265	0.00269	CcSEcCtD
Quinidine barbiturate—Anxiety—Lisinopril—dilated cardiomyopathy	0.000264	0.00268	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000263	0.00845	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000263	0.00845	CbGpPWpGaD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000263	0.00267	CcSEcCtD
Quinidine barbiturate—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.000263	0.00843	CbGpPWpGaD
Quinidine barbiturate—Confusional state—Lisinopril—dilated cardiomyopathy	0.000256	0.0026	CcSEcCtD
Quinidine barbiturate—Oedema—Lisinopril—dilated cardiomyopathy	0.000254	0.00258	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000252	0.0081	CbGpPWpGaD
Quinidine barbiturate—Shock—Lisinopril—dilated cardiomyopathy	0.00025	0.00254	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000249	0.00253	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000248	0.00253	CcSEcCtD
Quinidine barbiturate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000248	0.00252	CcSEcCtD
Quinidine barbiturate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000246	0.00251	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000245	0.0025	CcSEcCtD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.000243	0.0078	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Furosemide—dilated cardiomyopathy	0.000243	0.00247	CcSEcCtD
Quinidine barbiturate—Anorexia—Lisinopril—dilated cardiomyopathy	0.000242	0.00246	CcSEcCtD
Quinidine barbiturate—Pruritus—Furosemide—dilated cardiomyopathy	0.000239	0.00243	CcSEcCtD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000239	0.00767	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Lisinopril—dilated cardiomyopathy	0.000237	0.00241	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000232	0.00746	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000232	0.00745	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000231	0.00235	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000231	0.00235	CcSEcCtD
Quinidine barbiturate—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00023	0.0074	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000226	0.0023	CcSEcCtD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.000226	0.00725	CbGpPWpGaD
Quinidine barbiturate—Somnolence—Lisinopril—dilated cardiomyopathy	0.000226	0.00229	CcSEcCtD
Quinidine barbiturate—Dizziness—Furosemide—dilated cardiomyopathy	0.000224	0.00228	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000223	0.00716	CbGpPWpGaD
Quinidine barbiturate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000221	0.00224	CcSEcCtD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.00022	0.00706	CbGpPWpGaD
Quinidine barbiturate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000219	0.00223	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.000218	0.00699	CbGpPWpGaD
Quinidine barbiturate—Pain—Lisinopril—dilated cardiomyopathy	0.000217	0.00221	CcSEcCtD
Quinidine barbiturate—Constipation—Lisinopril—dilated cardiomyopathy	0.000217	0.00221	CcSEcCtD
Quinidine barbiturate—Vomiting—Furosemide—dilated cardiomyopathy	0.000215	0.00219	CcSEcCtD
Quinidine barbiturate—Rash—Furosemide—dilated cardiomyopathy	0.000213	0.00217	CcSEcCtD
Quinidine barbiturate—Dermatitis—Furosemide—dilated cardiomyopathy	0.000213	0.00217	CcSEcCtD
Quinidine barbiturate—Headache—Furosemide—dilated cardiomyopathy	0.000212	0.00216	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000209	0.00213	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000207	0.00211	CcSEcCtD
Quinidine barbiturate—Urticaria—Lisinopril—dilated cardiomyopathy	0.000202	0.00205	CcSEcCtD
Quinidine barbiturate—Nausea—Furosemide—dilated cardiomyopathy	0.000201	0.00204	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000201	0.00204	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000201	0.00204	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000198	0.00635	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000187	0.0019	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000185	0.00595	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000185	0.00595	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.000182	0.00585	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Lisinopril—dilated cardiomyopathy	0.000182	0.00185	CcSEcCtD
Quinidine barbiturate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00018	0.00183	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000178	0.0057	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000174	0.00177	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—RAF1—dilated cardiomyopathy	0.000168	0.0054	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Lisinopril—dilated cardiomyopathy	0.000168	0.00171	CcSEcCtD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.000167	0.00535	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000165	0.00529	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.000164	0.00526	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000163	0.00522	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Lisinopril—dilated cardiomyopathy	0.000161	0.00164	CcSEcCtD
Quinidine barbiturate—Rash—Lisinopril—dilated cardiomyopathy	0.00016	0.00163	CcSEcCtD
Quinidine barbiturate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00016	0.00163	CcSEcCtD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00016	0.00513	CbGpPWpGaD
Quinidine barbiturate—Headache—Lisinopril—dilated cardiomyopathy	0.000159	0.00162	CcSEcCtD
Quinidine barbiturate—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000158	0.00507	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000151	0.00486	CbGpPWpGaD
Quinidine barbiturate—Nausea—Lisinopril—dilated cardiomyopathy	0.000151	0.00153	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000147	0.00472	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000143	0.00459	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000139	0.00447	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000139	0.00445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.000128	0.00412	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00011	0.00354	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000109	0.00349	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000107	0.00344	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000107	0.00344	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.000107	0.00343	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	9.96e-05	0.0032	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	9.96e-05	0.0032	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	9.93e-05	0.00319	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—RAF1—dilated cardiomyopathy	9.74e-05	0.00313	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	9.42e-05	0.00302	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	9.39e-05	0.00302	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	9.14e-05	0.00293	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	9.14e-05	0.00293	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	8.82e-05	0.00283	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	8.71e-05	0.0028	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	8.66e-05	0.00278	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	8.5e-05	0.00273	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.49e-05	0.00273	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	8.42e-05	0.0027	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	8.24e-05	0.00265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	8.24e-05	0.00265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	7.66e-05	0.00246	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	7.65e-05	0.00246	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	7.49e-05	0.00241	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	7.37e-05	0.00237	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	7.11e-05	0.00228	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	7.02e-05	0.00225	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	7e-05	0.00225	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	6.89e-05	0.00221	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	6.72e-05	0.00216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	6.55e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	6.55e-05	0.0021	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	6.24e-05	0.00201	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	6.21e-05	0.002	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	6.09e-05	0.00196	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	5.98e-05	0.00192	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	5.9e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	5.88e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—RAF1—dilated cardiomyopathy	5.74e-05	0.00184	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	5.58e-05	0.00179	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.44e-05	0.00175	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	5.32e-05	0.00171	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	5.3e-05	0.0017	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	5.27e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	5.27e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	5.07e-05	0.00163	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	5.04e-05	0.00162	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	4.99e-05	0.0016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	4.99e-05	0.0016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	4.99e-05	0.0016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	4.78e-05	0.00154	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	4.64e-05	0.00149	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	4.64e-05	0.00149	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	4.5e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	4.49e-05	0.00144	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	4.46e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	4.46e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	4.04e-05	0.0013	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	3.84e-05	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	3.64e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.58e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	3.55e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	3.45e-05	0.00111	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	3.31e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	3.18e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	3.06e-05	0.000981	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	2.92e-05	0.000937	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	2.82e-05	0.000906	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	2.82e-05	0.000906	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	2.81e-05	0.000901	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	2.74e-05	0.000881	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	2.7e-05	0.000867	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	2.62e-05	0.000842	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	2.56e-05	0.000822	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	2.56e-05	0.000822	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	2.54e-05	0.000815	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	2.48e-05	0.000797	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	2.38e-05	0.000765	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	2.31e-05	0.00074	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	2.27e-05	0.000729	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.17e-05	0.000698	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	2.17e-05	0.000696	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	2.16e-05	0.000695	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	2.06e-05	0.000661	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	1.97e-05	0.000632	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	1.87e-05	0.0006	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.85e-05	0.000595	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.7e-05	0.000547	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	1.6e-05	0.000513	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	1.53e-05	0.00049	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.51e-05	0.000486	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.51e-05	0.000486	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.45e-05	0.000466	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.41e-05	0.000452	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	1.39e-05	0.000445	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.36e-05	0.000437	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.16e-05	0.000374	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.1e-05	0.000354	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.62e-06	0.000309	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.48e-06	0.000305	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	8.57e-06	0.000275	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	8.19e-06	0.000263	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	6.74e-06	0.000216	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.59e-06	0.000212	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	6.56e-06	0.000211	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	5.91e-06	0.00019	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.68e-06	0.000182	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.9e-06	0.000125	CbGpPWpGaD
